Figure 4From: In vitro and in vivo anti-malarial activity of tigecycline, a glycylcycline antibiotic, in combination with chloroquine Survival pattern of Plasmodium berghei -infected mice treated with [A] chloroquine (CQ); [B] tigecycline (TG) once daily dose; [C] tigecycline (TG) split dose; and, [D] combination of tigecycline (TG) and chloroquine (CQ). Back to article page